Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined vs. Single Antibiotic Therapy for Typhoid Fever
NCT02224040Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Aug 2013
- Primary completion
- Dec 2014
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone, azithromycin, cefixime in typhoid fever, sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
ceftriaxoneazithromycincefixime
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT02224040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02224040.